Effect of Concurrent Use of Memantine on the Efficacy of Masupirdine (SUVN-502): A Post Hoc Analysis of a Phase 2 Randomized Placebo-Controlled Study

por Nirogi, Ramakrishna, Goyal, Vinod Kumar, Benade, Vijay, Subramanian, Ramkumar, Ravula, Jyothsna, Jetta, Satish, Shinde, Anil, Pandey, Santosh Kumar, Jayarajan, Pradeep, Jasti, Venkat, Cummings, Jeffrey
Publicado 2022

Effect of masupirdine (SUVN‐502) on cognition in patients with moderate Alzheimer's disease: A randomized, double‐blind, phase 2, proof‐of‐concept study

por Nirogi, Ramakrishna, Ieni, John, Goyal, Vinod Kumar, Ravula, Jyothsna, Jetta, Satish, Shinde, Anil, Jayarajan, Pradeep, Benade, Vijay, Palacharla, Veera Raghava Chowdary, Dogiparti, Dhanunjay Kumar, Jasti, Venkat, Atri, Alireza, Cummings, Jeffrey
Publicado 2022

Potential beneficial effects of masupirdine (SUVN‐502) on agitation/aggression and psychosis in patients with moderate Alzheimer's disease: Exploratory post hoc analyses

por Nirogi, Ramakrishna, Jayarajan, Pradeep, Benade, Vijay, Shinde, Anil, Goyal, Vinod Kumar, Jetta, Satish, Ravula, Jyothsna, Abraham, Renny, Grandhi, Venkata Ramalingayya, Subramanian, Ramkumar, Pandey, Santosh Kumar, Badange, Rajesh Kumar, Mohammed, Abdul Rasheed, Jasti, Venkat, Ballard, Clive, Cummings, Jeffrey
Publicado 2022